# Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia

> **NCT04324411** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Autoimmune Anemia

## Interventions

- **DRUG:** sirolimus and ATRA

## Key facts

- **NCT ID:** NCT04324411
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04324411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04324411, "Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04324411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*